Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M579Revenue $M363Net Margin (%)-1.6Altman Z-Score1.6
Enterprise Value $M859EPS $-0.2Operating Margin %2.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.5Pre-tax Margin (%)-0.9Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales1.45-y EBITDA Growth Rate %--Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow30.3y-y EBITDA Growth Rate %37.5ROA % (ttm)-1.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-2.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M35.5ROIC % (ttm)49.3Gross Margin Increase y-yN

Gurus Latest Trades with AMRI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRIKen Fisher 2015-12-31 Add$17.08 - $20.5
($19.03)
$ 15.45-19%Add 19.06%203,450
AMRIKen Fisher 2015-09-30 Buy 0.01%$17.23 - $22.2
($20.37)
$ 15.45-24%New holding170,876
AMRIJoel Greenblatt 2014-09-30 Sold Out -0.03%$18.7 - $22.89
($20.45)
$ 15.45-24%Sold Out0
AMRIJoel Greenblatt 2014-06-30 Reduce-0.03%$14.63 - $19.89
($16.89)
$ 15.45-9%Reduce -47.95%102,934
AMRIGeorge Soros 2014-06-30 Sold Out -0.01%$14.63 - $19.89
($16.89)
$ 15.45-9%Sold Out0
AMRIGeorge Soros 2014-03-31 Buy 0.01%$10.08 - $19.91
($13.57)
$ 15.4514%New holding48,700
AMRIJoel Greenblatt 2013-09-30 Buy 0.1%$10.81 - $13.72
($12.29)
$ 15.4526%New holding228,216
AMRIJohn Rogers 2013-03-31 Sold Out -0.04%$5.28 - $10.84
($7.56)
$ 15.45104%Sold Out0
AMRIJohn Rogers 2012-12-31 Reduce-0.01%$3.45 - $5.5
($4.25)
$ 15.45264%Reduce -27.34%372,844
AMRIJohn Rogers 2012-06-30 Buy 0.03%$2.32 - $3.22
($2.81)
$ 15.45450%New holding473,769
AMRIFirst Eagle Investment 2010-12-31 Sold Out $5.05 - $6.93
($5.92)
$ 15.45161%Sold Out0
AMRIFirst Eagle Investment 2010-06-30 Buy $5.1 - $8.86
($7.07)
$ 15.45119%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AMRI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
D AMBRA THOMAS EChairman, Board of Directors 2015-11-09Sell50,000$19.6-21.17view
D AMBRA CONSTANCE M10% Owner 2015-11-09Sell50,000$19.6-21.17view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-08-17Sell1,000$20.45-24.45view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-08-07Sell5,000$21.06-26.64view
D AMBRA THOMAS E PHDDirector 2015-06-10Sell20,000$19.77-21.85view
D AMBRA CONSTANCE M10% Owner 2015-06-10Sell20,000$19.77-21.85view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-06-08Sell5,000$19.99-22.71view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-06-04Sell787$19.58-21.09view
Marth William SPresident and CEO 2015-06-04Buy10,000$19.98-22.67view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-06-02Sell3,750$19.39-20.32view

Quarterly/Annual Reports about AMRI:

    News about AMRI:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN Dec 05 2011 

    More From Other Websites
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Change in Directors or Principal Officers,... Feb 05 2016
    AMRI Appoints Anthony J. Maddaluna to Board of Directors Feb 04 2016
    AMRI Announces Executive Hire to Lead Active Pharmaceutical Ingredients Business Jan 20 2016
    AMRI partners with Center for Nanomedicine Research on co-marketing deal Jan 14 2016
    AMRI and NYCNMR Form Collaborative Agreement Jan 14 2016
    AMRI and NYCNMR Form Collaborative Agreement Jan 14 2016
    AMRI Announces 3-Year Extension of Insourcing Contract Jan 12 2016
    Eagle Pharmaceuticals and AMRI Announce Agreement to Jointly Develop, Manufacture and Commercialize... Jan 11 2016
    AMRI Announces First Product Approval Out of its Massachusetts Aseptic Fill Finish Site Jan 11 2016
    AMRI Date and Time Change for J.P. Morgan Healthcare Conference Presentation Jan 10 2016
    Albany Molecular Research, Icagen Announce New Agreement That Combines Both Companies' Assets Jan 07 2016
    AMRI and Icagen Ink Collaboration Agreement Jan 07 2016
    Albany Molecular Research, Inc. breached its 50 day moving average in a Bearish Manner : January 5,... Jan 05 2016
    AMRI CEO to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 04 2016
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Dec 21 2015
    Albany Molecular Research, Inc. -- Moody's: AMRI's acquisition of Whitehouse Labs is credit positive Dec 17 2015
    Albany Molecular Research, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 17 2015
    AMRI acquires New Jersey testing service for $54 million Dec 15 2015
    AMRI Acquires Whitehouse Laboratories Dec 15 2015
    AMRI and Multispan Ink Collaboration Agreement Dec 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK